approval · primary record
GLOFITAMAB-GXBM
FDA · BLA · 2026-06-22
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-06-22 |
| Brand | COLUMVI |
| Sponsor | GENENTECH INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:58.222Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:GLOFITAMAB-GXBM:2026-06-22
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.